Dr. Mone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
379 Campus Dr
Fl 4
Somerset, NJ 08873Phone+1 732-937-8939Fax+1 201-533-0223
Summary
- Dr. Suzanne Mone is a pediatric cardiologist in Hoboken, NJ and is affiliated with Cooperman Barnabas Medical Center in Livingston, NJ. She received her medical degree from St. George's University School of Medicine and has been in practice 15 years. She specializes in fetal cardiology, pediatric echocardiography, and pediatric exercise physiology.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Cardiology, 2005 - 2006
- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Cardiology, 2002 - 2005
- University of RochesterResidency, Pediatrics, 1999 - 2002
- St. George's University School of MedicineClass of 1999
Certifications & Licensure
- NJ State Medical License 2007 - 2025
- MO State Medical License 2023 - 2024
- NY State Medical License 2007 - 2022
- CA State Medical License 2005 - 2021
- OH State Medical License 2002 - 2008
- PA State Medical License 2000 - 2008
- American Board of Pediatrics Pediatric Cardiology
Publications & Presentations
PubMed
- 492 citationsChronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic LeukemiaSteven E. Lipshultz, Stuart R. Lipsitz, Stephen E. Sallan, Virginia M. Dalton, Suzanne M. Mone
Journal of Clinical Oncology. 2005-04-20 - 203 citationsLong-Term Enalapril Therapy for Left Ventricular Dysfunction in Doxorubicin-Treated Survivors of Childhood CancerSteven E. Lipshultz, Stuart R. Lipsitz, Stephen E. Sallan, Valeriano C. Simbre, Seema L. Shaikh
Journal of Clinical Oncology. 2002-12-01 - 570 citationsFemale sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.Steven E. Lipshultz, Lipsitz, Suzanne M. Mone, Allen M. Goorin, Stephen E. Sallan
The New England Journal of Medicine. 1995-06-29
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: